LATEST NEWS

I had a very positive experience under the care of Mr John Chaplin. From the initial consultation through to surgery and follow-up, he was extremely thorough and professional. He took the time to carefully investigate the issue, explain the results clearly, and outline the treatment options and next steps so that I always felt well informed. I also appreciated the clarity of the treatment plan and knowing what to expect at each stage. What I particularly appreciated was that

WHO Tumour Classification 5th Edition 2022 has introduced changes that alter some of the nomenclature previously used for follicular cell derived thyroid tumours. I will outline these changes here and add to a previously published article I had on this site. TYPES OF THYROID CANCER AN UPDATE 2026 There are several different types of thyroid cancers and they are broadly broken into categories based on the cells that they originate from and their behaviour. Most thyroid canc

Molecular Testing for Thyroid Nodules What is Molecular Testing? Molecular testing is an advanced laboratory technique that analyses the genetic material (DNA and RNA) within thyroid nodule cells obtained during a fine needle aspiration (FNA) biopsy. By looking for specific gene mutations, gene fusions, and other genetic alterations, molecular testing helps determine whether a thyroid nodule is likely to be benign (non-cancerous) or malignant (cancerous). It is particularly h

John has recently returned from a conference in Egypt organised by Professor Hisham Mehanna who was Head and neck fellow in Auckland in 2003-2004 and is now Professor of Head and Neck Surgery at the University of Birmingham , Honorary Consultant Head and Neck and Thyroid Surgeon at University Hospitals Birmingham NHS Foundation Trust , and Director of the Institute of Head and Neck Studies and Education (InHANSE). Originally Egyptian and brought up in the UAE, Hisham, who Joh